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‘Orujo’ olive oil is obtained by chemical processes from the waste resulting from the mechanical extraction of virgin olive oil. The aim of
the present study was to evaluate a new pharmacological property of two natural triterpenoids contained in olive oil, as vasodilatory agents,
and to determine their mechanism of action. The two compounds studied were oleanolic acid and erythrodiol. The vasorelaxant effect
induced by these pentacyclic triterpenoids was studied in isolated thoracic rat aorta. Oleanolic acid and erythrodiol, accumulatively
added, showed vasorelaxant activities in aortic rings with endothelium pre-contracted by 1026 M-phenylephrine (maximum percentage
of relaxation 86·38 (SEM 2·89) and 73·53 (SEM 6·01), respectively). They had almost no relaxant effect on depolarised or endothelium-
denuded aortic segments. The relaxation was significantly attenuated by pre-treatment with the NO synthase inhibitor Nv-nitro-L-argi-
nine-methylester (L-NAME; 3 £ 1024 M). To characterise the involvement of endothelial factors, in addition to NO, arteries with
endothelium were exposed to 1025 M-indomethacin (INDO), a cyclo-oxygenase inhibitor, or INDO plus L-NAME. INDO did not have
any significant effect on the relaxant response of both compounds. The combination of L-NAME plus INDO only abolished the oleanolic
acid-induced relaxation. The present results suggest that the mechanism of relaxation seems to be mainly mediated by the endothelial pro-
duction of NO; however, other mechanisms cannot be excluded. It can be concluded that oleanolic acid and erythrodiol may have inter-
esting therapeutic potential as new vasodilator drugs, thus protecting the cardiovascular system. Therefore, the intake of ‘orujo’ olive oil,
as a source of these compounds, might be beneficial in this regard.
‘Orujo’ olive oil: Oleanolic acid: Erythrodiol: Vasorelaxation: Endothelium: Rat aorta
Epidemiological studies and clinical trials demonstrate that
a suitable diet may reduce the occurrence of cardiovascular
disorders (Keys, 1995). In recent years, there has been a
growing interest in fortified and enhanced foods, referred
to as ‘functional foods’ or ‘nutraceuticals’. It is noteworthy
that phytochemicals or components in these functional
foods, when consumed at effective levels as part of a
varied diet, may provide some health benefits (American
Dietetic Association, 1999).
The importance of olive oil as an integral ingredient of
the Mediterranean diet is well known, and some evidence
suggests that it may have health benefits on inflammatory
and cardiovascular events (Visioli & Galli, 1998; De la
Puerta et al. 1999; Perona & Ruı´z-Gutie´rrez, 2000). The
varied olive oil components seem to be responsible for
these therapeutic characteristics.
‘Orujo’ olive oil, as called in Spain, is obtained by
chemical processes from the mechanical extraction of
virgin olive oil. To our knowledge, the potential thera-
peutic significance of this olive sub-product has not yet
been studied. It is expected that subsequent investigations
will allow the discovery of the functional properties of
‘orujo’ olive oil, due to its potentially beneficial com-
ponents (e.g. tetra- and pentacyclic triterpenes), which
are in a lower concentration in virgin and refined olive
oil (Vioque & Maza, 1963; Va´zquez-Roncero & Janer,
1969). The present study is focused on oleanolic acid
(3b-hydroxyolean-12-en-28-oic acid) and erythrodiol
(3b-olean-12-en-28-diol), a pentacyclic triterpenoid acid
and alcohol respectively (Fig. 1). The solid waste called
‘orujo’ resulting from the olive oil extraction contains a
blend of olive leaves, cuticle and surface, which are a
source of these triterpenoids. Thus, ‘orujo’ oil contains
oleanolic acid and erythrodiol in a high concentration, in
contrast to olive oil (Vioque & Morris, 1961; Pe´rez-
Camino & Cert, 1999).
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The pharmacological effects of erythrodiol have not
been studied in detail. Only the therapeutic efficiency of
erythrodiol on different experimental models of inflam-
mation has been reported (Recio et al. 1995; Man˜ez et al.
1997; De la Puerta et al. 2000). However, many studies on
oleanolic acid have been published. These reports have
demonstrated a very wide range of biological and pharma-
cological properties of this triterpenoid acid. Many of them
were summarised by Liu (1995). These properties include,
among others, anti-inflammatory (Ringbom et al. 1998;
Honda et al. 2000), anti-tumoral (Hsu et al. 1997; Choi
et al. 2001), hepatoprotective (Liu et al. 1998; Yim et al.
2001), anti-diabetogenic (Matsuda et al. 1998; Yoshikawa
& Matsuda, 2000) and anti-HIV activities (Kashiwada et al.
1998; Zhu et al. 2001; Mengoni et al. 2002). There is
scarce evidence about the pharmacological effects of ery-
throdiol and oleanolic acid on vascular events; only the
cardiovascular effects of oleanolic acid and its isomer urso-
lic acid have been recently studied and published by
Somova et al. (2003a,b). They have shown that the chronic
treatment of Dahl salt-sensitive hypertensive rats with
these natural compounds prevents the development of
hypertension with significant bradycardia and potent diure-
tic activity.
Our interest in both oleanolic acid and erythrodiol on the
cardiovascular system arises from their anti-inflammatory
properties mentioned earlier. Inflammation has been
recently linked to the atherogenic process, which also
impairs endothelial function (Libby, 2002), and it is related
to vascular reactivity. Therefore, we now report for the first
time a study of the possible vasodilatory effects of oleano-
lic acid and erythrodiol in rat thoracic aorta and the influ-
ence of endothelium-derived factors in these actions. The
underlying mechanism implicated in their vasorelaxant
responses was also investigated, using different experimen-
tal protocols.
Materials and methods
Experimental animals
The pharmacological experiments were carried out on adult
male Wistar rats (10–12 weeks old) weighing 250–300 g,
and fed on standard rat chow with free access to drinking
water. All experiments were performed according to the
guidelines for the ethnical treatment of animals of the
European Union.
Aortic ring preparation
The animals were killed by cervical dislocation and the
descending thoracic aorta was rapidly dissected and
transferred into modified Krebs–Henseleit solution of the
following composition (mM): NaCl, 118; KCl, 4·75;
NaHCO3, 25; MgSO4, 1·2; CaCl2, 1·8; KH2PO4, 1·2;
glucose, 11.
The aortas were cleaned of adherent tissue and cut into
2–3 mm rings. Each ring was fixed horizontally under a
resting tension of 2 g in a 10 ml organ-bath filled with
Krebs–Henseleit solution. The solution was continuously
kept at 378C and gassed with 95 % O2 and 5 % CO2 at
pH 7·4. Mechanical activity was recorded isometrically
by a force-displacement transducer (Pioden UF-1; Pioden
Controls Ltd, Canterbury, Kent, UK) connected to a
Powerlab data acquisition system (ADInstruments Pty
Ltd; Castle Hill, New South Wales, Australia), as pre-
viously described (A´lvarez de Sotomayor et al. 2001).
After an equilibration period of 60 min, aortic rings were
contracted with 1026 M-phenylephrine to test their contrac-
tile capacity. In some experiments, the endothelial layer
was removed immediately after dissection by gently rub-
bing the intimal surface of the intact vessel. The presence
of functional endothelium was confirmed in all prep-
arations by determining the ability of 1026 M-acetylcholine
to induce more than 50 % relaxation of rings pre-contracted
with 1026 M-phenylephrine. The absence of a relaxation
response to acetylcholine was taken as evidence that the
aortic segments were functionally denuded of endothelium.
Vascular relaxation experiments
For the assessment of vasorelaxation property and potency,
the aortic rings were first pre-contracted at 80 % of their
maximal contraction with 1026 M-phenylephrine or KCl
(25 or 80 mM). When the contractile responses reached a
plateau, cumulative concentrations of oleanolic acid or ery-
throdiol (1027 to 1024 M) were added to the bath medium
at 20 min intervals (the time necessary to obtain a steady-
state relaxation) to study the relaxation induced by these
two compounds. The same procedure was repeated in
endothelium-denuded aortic rings.
We also performed another set of experiments, in order
to elucidate the mechanism of action of oleanolic acid and
erythrodiol. Rings with functional endothelium were pre-
incubated with the following inhibitors: the NO synthase
inhibitor Nv-nitro-L-arginine methyl ester (L-NAME;
3 £ 1024 M), the cyclo-oxygenase (COX) inhibitor indo-
methacin (INDO; 1025 M), the thromboxane A2–prostaglan-
din H2 receptor (Tp) antagonist, ICI 192,605 (10
25
M),
or a combination of the superoxide anion (O2
2) scavenger,
superoxide dismutase (SOD; 150 U/ml) plus the H2O2
inactivator, catalase (1000 U/ml). Sarcoplasmic reticulum
Ca2þ–ATPase involvement was investigated by using
3 £ 1025 M-cyclopiazonic acid, added to the bath at the
same time as phenylephrine. L-NAME and INDO were incu-
bated with the tissues for 20 min before the pre-contraction
with the agonist. ICI 192,605 was incubated for 30 min,
and the combination of SOD plus catalase was added
15 min before the agonist application. Different aortic rings
from different animals were used in each experiment. All
the results were expressed as a percentage of the maximal
contraction of phenylephrine-induced responses.
Fig. 1. Chemical structures of (A) oleanolic acid and (B) erythrodiol.
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Drugs
The following drugs were used: oleanolic acid and erythro-
diol (Extrasynthese, Genay, France), acetylcholine chloride,
INDO, L-NAME, phenylephrine hydrochloride, superoxide
dismutase and catalase (Sigma Chemical Co., St Louis,
MO, USA), and ICI 192,605 and cyclopiazonic acid
(Tocris, Biogen Cientifica S.L., Madrid, Spain). Stock sol-
utions were prepared in distilled deionised water except olea-
nolic acid, erythrodiol, INDO, ICI 192,605 and
cyclopiazonic acid, which were dissolved in dimethylsulfox-
ide. The final dimethylsulfoxide concentration (,0·01 %) in
the tissue-bath did not significantly influence vascular
responses. All concentrations of the drugs used are expressed
as their final concentration in the organ chamber.
Statistical analysis
Results are expressed as percentages from the initial pre-
contraction level and as mean values and standard errors
of the mean of six to eight rats per group. Dose–response
slopes were analysed to give the concentration of oleanolic
acid and erythrodiol required to produce 50 % of the maxi-
mal relaxation. Statistically significant differences were
evaluated by an ANOVA followed by the least significant
difference test. P values of ,0·05 were considered to indi-
cate a significant difference. In figures, all error bars have
been removed, since they are smaller than the symbol size.
The data analyses were performed with the GraphPad
Prismw statistical package (version 3.00; GraphPad Soft-
ware Inc., San Diego, CA, USA).
Results
Effects on phenylephrine-induced contractions: influence
of endothelium
As illustrated in Fig. 2, oleanolic acid and erythrodiol
induced a vasorelaxant response in a concentration-depen-
dent manner in endothelium-intact aortas pre-contracted by
1026 M-phenylephrine. The vasorelaxant effect of these tri-
terpenoids was also analysed in mechanically denuded
aortas. Removal of the endothelium markedly attenuated
the relaxant effects on contractions evoked by phenyl-
ephrine (Fig. 2). The maximal response to oleanolic acid
or erythrodiol at 1024 M was decreased in aortic rings with-
out endothelium (Table 1).
Effects on potassium chloride-induced contractions
The effects of oleanolic acid and erythrodiol on low
(25 mM) and high (80 mM) KCl-evoked contractions were
studied. In aortic rings with an intact endothelial layer
pre-contracted by 25 mM-KCl, both triterpenoids elicited
a moderate vasorelaxation (Fig. 3), with lower values of
maximum percentage of relaxation, compared with those
obtained in phenylephrine-contracted aortas. The maximal
relaxant effects of both triterpenoids in depolarised aortas
(80 mM-KCl) were significantly lower than those obtained
in 25 mM-KCl-pre-contracted aortic segments (Table 1).
Characterisation of endothelial factors involved in the
relaxant effect
To measure the influence of NO on the endothelium-depen-
dent relaxation induced by oleanolic acid or erythrodiol,
the effect of the NO synthase inhibitor, L-NAME
(3 £ 1024 M), was studied. In these conditions, L-NAME
produced a significant reduction of the relaxation induced
by both triterpenic compounds in endothelium-intact rat
aortic rings (Fig. 4). In another set of experiments, the
involvement of prostanoids derived from the COX pathway
in the vasorelaxation was also tested. Some differences
between oleanolic acid responses and erythrodiol responses
were observed.
The blockage of COX by 1025 M-INDO did not affect
the oleanolic acid-induced relaxation. However, when
NO synthase and COX were blocked together, the relax-
ation response was significantly attenuated and this finding
was similar to that obtained in denuded arteries, as shown
in Fig. 5 (A). When the aortas were incubated with the Tp
receptor antagonist ICI 192,605 (1025 M), the relaxation of
arteries pre-contracted with phenylephrine induced by
oleanolic acid was not altered (Fig. 6 (A)).
On the other hand, for erythrodiol, pre-treatment of
the rings with 1025 M-INDO did not affect the endo-
thelium-dependent vasorelaxation (Fig. 5 (B)). In contrast
to oleanolic acid, exposure to 1025 M-INDO plus
3 £ 1024 M-L-NAME did not result in a further alteration
in relaxation induced by erythrodiol compared with
INDO alone. Fig. 6 (B) shows that 1025 M-ICI 192,605
was able to slightly but significantly (P,0·05) increase
Fig. 2. Relaxant effects of oleanolic acid (A) and erythrodiol (B) in
aortic rings pre-contracted by 1026 M-phenylephrine. (X), Control
arteries with intact endothelium; (W), denuded arteries. Values are
means for six rats per group. ***Response curve was significantly
different from that for the control with endothelium (P,0·001).
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the endothelial relaxant response to erythrodiol in intact
arteries. However, the concentration–response curve to
erythrodiol was significantly different in the presence of
ICI 192,605 alone or in combination with L-NAME.
Finally, to test whether an augmented production of
superoxide anion and H2O2 is involved in the endo-
thelium-dependent relaxation induced by oleanolic acid
or erythrodiol, arteries were pre-treated with SOD
Table 1. Maximum percentage of relaxation (Emax) induced by oleanolic acid and erythrodiol and concen-
trations of oleanolic acid and erythrodiol required to produce 50 % of Emax (EC50) in intact or denuded
aortic rings pre-contracted by 1026 M-phenylephrine or potassium chloride (80 or 25 mM) (six to eight rats
per group)
(Mean values and standard errors of the mean)
Oleanolic acid Erythrodiol
Emax (%) EC50 (mM) Emax (%) EC50 (mM)
Mean SEM Mean SEM Mean SEM Mean SEM
Endothelium intact
Phenylephrine 86·38 2·89 5·58 1·28 73·54 6·01 3·38 1·27
L-NAME 28·15*** 2·96 ND 25·50*** 3·85 ND
INDO 80·54 3·94 14·5 1·54 57·70 6·76 3·86 1·41
INDO þ L-NAME 43·90*** 4·97 ND 70·33 8·52 5·22 1·20
ICI 192,605 72·14 6·45 0·63 1·47 74·94 6·87 0·69 1·37
ICI þ L-NAME 36·95*** 4·54 ND 43·56*** 3·85 ND
CPA 12·55*** 9·16 ND 23·39*** 6·94 ND
KCl (80 mM) 29·71*** 3·55 ND 27·02*** 6·69 ND
KCl (25 mM) 52·33*** 6·30 12·5 1·77 39·25*** 3·06 ND
Endothelium denuded
Phenylephrine 34·42*** 3·28 ND 34·38*** 2·79 ND
CPA 48·64*** 4·07 ND 46·92*** 5·14 ND
KCl (80 mM) 33·00*** 4·21 ND 32·00*** 3·59 ND
KCl (25 mM) 54·46*** 5·91 4·73 1·55 60·91** 4·70 5·98 1·62
L-NAME, Nv-nitro-L-arginine methylester; ND, could not be calculated; INDO, indomethacin; CPA, cyclopiazonic acid.
Mean value was significantly different from that for intact aorta pre-contracted by phenylephrine: **P,0·01, ***P,0·001.
For details of drugs and procedures, see pp. 636–637.
Fig. 3. Relaxant effects of oleanolic acid (A) and erythrodiol (B) in
aortic rings pre-contracted by 80 mM-KCl with (B) and without (A)
endothelium, or by 25 mM-KCl with (O) and without (D) endothelium.
Values are means for six rats per group. *Response curve was sig-
nificantly different from that for intact aorta pre-contracted by
80 mM-KCl (P,0·05). ††Response curve was significantly different
from that for denuded aorta pre-contracted by 80 mM-KCl (P,0·01).
Fig. 4. Relaxant effects of oleanolic acid (A) and erythrodiol (B) in
aortic rings with functional endothelium pre-contracted by 1026
M-phenylephrine. (X), Control arteries; (O), arteries in the presence
of 3 £ 1024 M-Nv-nitro-L-arginine-methylester. Values are means for
six rats per group. ***Response curve was significantly different
from that for the control (P,0·001).
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(150 U/ml) plus catalase (1000 U/ml). But, as shown in
Fig. 7, the relaxations due to oleanolic acid or erythrodiol
were not affected by the combination of these reactive
oxygen species scavengers.
Effect of Ca2þ–ATPase inhibition on oleanolic acid and
erythrodiol-induced relaxations
Inhibition of sarcoplasmic reticulum Ca2þ–ATPase with
3 £ 1025 M-cyclopiazonic acid was able to significantly
decrease the relaxant effects of oleanolic acid and erythro-
diol in aortic rings with endothelium (Fig. 8). On the other
hand, in endothelium-denuded arteries, the presence of
cyclopiazonic acid slightly increased the relaxation
induced by oleanolic acid or erythrodiol (Fig. 8).
Discussion
The present study investigates, for the first time, the vasore-
laxant activity of oleanolic acid and erythrodiol in rat aorta.
In the present experiments, we have studied the ability of
both compounds, accumulatively added to the organ-bath
medium, to induce a relaxation of contractions caused by
different agonists, KCl or phenylephrine, in isolated rat
aorta. The results clearly show that oleanolic acid and ery-
throdiol are able to relax, in a concentration-dependent
fashion, the contractions induced by phenylephrine in rat
aortic rings with functional endothelium. However, these
Fig. 7. Relaxant effects of oleanolic acid (A) and erythrodiol (B)
in aortic rings with functional endothelium pre-contracted by
1026 M-phenylephrine. (X), Control arteries; (D), arteries in the pre-
sence of superoxide dismutase (150 U/ml) plus catalase
(1000 U/ml). Values are means for six rats per group.
Fig. 5. Relaxant effects of oleanolic acid (A) and erythrodiol (B)
in aortic rings with functional endothelium pre-contracted by
1026 M-phenylephrine. (X), Control arteries; (D), arteries in the pre-
sence of 1025 M-indomethacin (INDO); (B), arteries in the presence
of 1025 M-INDO plus 3 £ 1024 M-Nv-nitro-L-arginine-methylester.
Values are means for six to eight rats per group. ***Response
curve was significantly different from that for the control (P,0·001).
†Response curve was significantly different from that for aortic
rings in the presence of 1025 M-INDO alone (P,0·05).
Fig. 6. Relaxant effects of oleanolic acid (A) and erythrodiol (B)
in aortic rings with functional endothelium pre-contracted by
1026 M-phenylephrine. (X), Control arteries; (D), arteries in the pre-
sence of 1025 M-ICI 192,605; (B), arteries in the presence of 1025
M-ICI 192,605 plus 3 £ 1024 M-Nv-nitro-L-arginine-methylester.
Values are means for six rats per group. Response curves were
significantly different from control: *P,0·05, **P,0·01,
***P,0·001.
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responses were less marked in arteries pre-contracted by KCl
and in endothelium-denuded arteries. It is has been reported
that high Kþ concentrations cause contractions in vascular
smooth muscle by depolarising cell membranes and by
increasing the influx of Ca2þ through long-lasting voltage-
dependent channels (Godfraind et al. 1986). In this way,
the absence of relaxation in 80 mM-KCl-evoked contractions
might probably remove either the influence of membrane
hyperpolarisation or the contribution of the blockage of Ca
entry through voltage-stimulated Ca2þ channels to the relax-
ant responses to oleanolic acid and erythrodiol.
The vascular endothelium has been shown by Furchgott
& Zawadzki (1980) to be of crucial importance in the
relaxation of blood vessels in response to acetylcholine
and some other naturally occurring vasodilator substances
(Furchgott & Vanhoutte, 1989). Although NO appears to
be the major vasodilator released by endothelial cells,
other substances may also play a role, including prostacy-
clin and the endothelium-derived hyperpolarising factor.
These endothelial-relaxing factors contribute to the protec-
tive role of the endothelium (Boulanger, 1999). It has
become clear that endothelial cells not only release relax-
ing factors but also produce contracting substances such
as endothelin, thromboxane A2 and prostaglandin H2
(Moncada et al. 1991) as well as reactive oxygen species
(Lu¨scher & Barton, 1997). The present in vitro study
shows that the absence of the endothelial layer significantly
attenuates the relaxant effects of oleanolic acid and ery-
throdiol. This indicates that these effects are due to an
indirect and/or direct action of both triterpenic compounds
on the vascular endothelium, increasing the release of
endogenous relaxing factors and/or inhibiting the pro-
duction of contracting factors derived from endothelium.
It has been previously reported in a well-established in
vitro model of vasomotion that triterpenoid-related com-
pounds, commonly found in plant species, elicit vasore-
laxation through the direct release of NO from vascular
endothelium (Kim et al. 1994; Tanner et al. 1999). In
this way, it was expected that oleanolic acid and erythro-
diol would have vasoactive effects related to NO derived
from endothelium. The present experiments have indeed
demonstrated an NO-mediated mechanism, since the endo-
thelium-dependent relaxation due to oleanolic acid or ery-
throdiol was blocked by pre-incubating the arteries with
the NO synthase inhibitor L-NAME. However, we cannot
rule out the participation of other mechanisms of action
in the vasorelaxant activity.
According to the relaxant effect of erythrodiol, NO did
not seem to be the only endothelial factor released by
this triterpenic alcohol addition. This conclusion is sup-
ported by the results obtained with the COX inhibitor and
with the Tp receptor antagonist. It is important to point
out that erythrodiol induced a persisting relaxation in the
presence of the simultaneous blockage of the NO release
and the COX pathway. In addition, a higher relaxation
was observed in the presence of the Tp receptor antagonist.
The relaxant effect induced by erythrodiol was more
emphatic in the absence of thromboxane A2–prostaglandin
H2 or Tp receptor action. The data reveal the possible par-
ticipation of these endothelial vasoconstrictor products
upon erythrodiol stimulation. The most likely candidate
for the endothelial vasoconstrictor factor from COX is
probably thromboxane A2 or other prostanoids acting on
the Tp receptor (Yang et al. 2002); however, further studies
are needed to support this proposed mechanism. These
results have not been observed for oleanolic acid.
The relationship between vascular endothelium and
oxygen-derived free radicals is known (Mombouli &
Vanhoutte, 1999; Vanhoutte, 2001). Superoxide anions are
known to be implicated in the breakdown of NO (Laight
et al. 1998). Moreover, superoxide anions are the source of
the secondary reactive oxygen species such as H2O2 and
hydroxyl radicals (Yang et al. 2002). Therefore, one of our
hypotheses was that oleanolic acid and erythrodiol may med-
iate their vascular effects via the protection of NO break-
down by superoxide anions, since these triterpenoids,
mainly oleanolic acid, have shown an antioxidant activity
(Somova et al. 2003a,b). In our experimental conditions,
the use of the superoxide anion and H2O2 scavengers, SOD
and catalase, did not modify the relaxations caused by olea-
nolic acid and erythrodiol. Thus, these results ruled out a
mechanism sensitive to exogenous SOD and catalase even
though a participation of intracellular reactive oxygen
species insensitive to these scavengers cannot be excluded.
In order to clarify the mechanism of relaxation, we have
also considered the involvement of intracellular Ca2þ
Fig. 8. Effects of oleanolic acid (A) and erythrodiol (B) in aortic
rings pre-contracted by 1026 M-phenylephrine. (X), Control arteries
with intact endothelium; (W), denuded arteries; (O), arteries with
endothelium in the presence of 3 £ 1025 M-cyclopiazonic acid;
(D), arteries without endothelium in the presence of 3 £ 1025
M-cyclopiazonic acid. Values are means for six to eight rats per
group. ***Response curve was significantly different from that for
the control with endothelium (P,0·001).
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concentration in the endothelial cell induced by oleanolic
acid and erythrodiol. For this purpose, we have used cyclo-
piazonic acid, which is a specific inhibitor of the sarcoplas-
mic reticulum Ca2þ–ATPase. The endothelium-dependent
relaxation induced by oleanolic acid and erythrodiol was
significantly reduced by incubating the aortic rings with
cyclopiazonic acid. In blood vessels, Ca2þ release and
the subsequent increase in cytosolic Ca2þ concentration
in endothelial cells could activate NO synthase and
induce the NO-mediated relaxation of aortic rings
(Lu¨ckhoff et al. 1988; Zheng et al. 1994). These data
suggest that the effects of these triterpenoids on the Ca2þ
homeostasis of endothelial cells might contribute to vasodi-
latation. Therefore, oleanolic acid and erythrodiol might
inhibit the sequestration of Ca2þ into intracellular stores
via sarcoplasmic reticulum Ca2þ–ATPase, thus increasing
intracellular Ca2þ in endothelial cells, and with the sub-
sequent NO synthase activation and NO release.
In conclusion, the results of the present study introduce
the first in vitro evidence that oleanolic acid and erythro-
diol evoke an endothelium-dependent vasorelaxation in
rat aorta. These preliminary results suggest that the mech-
anism of relaxation seems to be mainly mediated by the
endothelial production of NO; however, other mechanisms
cannot be excluded. Bearing in mind the pharmacological
effects showed earlier, it can be concluded that oleanolic
acid and erythrodiol may have interesting therapeutic
potential as new vasodilator drugs, thus protecting the car-
diovascular system. Therefore, the intake of ‘orujo’ olive
oil, as a source of these compounds, might be beneficial
in this regard. Additional experimentation is in progress
in order to provide new data for clarifying the precise
mechanism by which oleanolic acid and erythrodiol pro-
duce their characteristic in vitro vasorelaxant effects.
Acknowledgements
The present study was supported by funds from the Comi-
sio´n Interministerial de Ciencia y Tecnologı´a (CICYT)
(project AGL2002-00195) and Junta de Andalucı´a
(CAO01-002).
References
A´lvarez de Sotomayor M, Pe´rez-Guerrero C, Herrera MD &
Marhuenda E (2001) Effect of simvastatin on vascular
smooth muscle responsiveness: involvement of Ca(2 þ )
homeostasis. Eur J Pharmacol 415, 217–224.
American Dietetic Association (1999) Position of the American
Dietetic Association: functional foods. J Am Diet Assoc 99,
1278–1285.
Boulanger CM (1999) Secondary endothelial dysfunction: hyper-
tension and heart failure. J Mol Cell Cardiol 31, 39–49.
Choi CY, You HJ & Jeong HG (2001) Nitric oxide and tumor
necrosis factor-alpha production by oleanolic acid via nuclear
factor-kappaB activation in macrophages. Biochem Biophys
Res Commun 288, 49–55.
De la Puerta R, Martı´nez-Domı´nguez E & Ruı´z-Gutie´rrez V
(2000) Effect of minor components of virgin olive oil
on topical antiinflammatory assays. Z Naturforsch 55C,
814–819.
De la Puerta R, Ruı´z-Gutie´rrez V & Hoult JRS (1999) Inhibition
of leukocyte 5-lipooxygenase by phenolics from virgin olive
oil. Biochem Pharmacol 57, 445–449.
Furchgott RF & Vanhoutte PM (1989) Endothelium-derived
relaxing and contracting factors. FASEB J 3, 2007–2018.
Furchgott RF & Zawadzki JV (1980) The obligatory role of endo-
thelial cells in the relaxation of arterial smooth muscle by
acetylcholine. Nature 299, 373–376.
Godfraind T, Miller R & Wibo M (1986) Calcium antagonism
and calcium entry blockade. Pharmacol Rev 38, 321–416.
Honda T, Rounds BV, Bore L, Finlay HJ, Favaloro FG Jr, Suh N,
Wang Y, Sporn MB & Gribble GW (2000) Synthetic oleanane
and ursane triterpenoids with modified rings A and C: a series
of highly active inhibitors of nitric oxide production in mouse
macrophages. J Med Chem 43, 4233–4246.
Hsu HY, Yang JJ & Lin CC (1997) Effects of oleanolic acid and
ursolic acid on inhibiting tumor growth and enhancing the
recovery of hematopoietic system postirradiation in mice.
Cancer Lett 111, 7–13.
Kashiwada Y, Wang HK, Nagao T, et al. (1998) Anti-AIDS agents.
30. Anti-HIV activity of oleanolic acid, pomolic acid, and struc-
turally related triterpenoids. J Nat Prod 61, 1090–1095.
Keys A (1995) Mediterranean diet and public health: personal
reflections. Am J Clin Nutr 61, 1321S–1323S.
Kim ND, Kang SY & Schini VB (1994) Gingenosides evoke
endothelium-dependent vascular relaxation in rat aorta. Gen
Pharmacol 25, 1071–1077.
Laight DW, Kaw AV, Carrier MJ & Anggard EE (1998) Inter-
action between superoxide anion and nitric oxide in the regu-
lation of vascular endothelial function. Br J Pharmacol 124,
238–244.
Libby P (2002) Inflammation and atherosclerosis. Nature 420,
868–874.
Liu J (1995) Pharmacology of oleanolic acid and ursolic acid.
J Ethnopharmacol 49, 57–68.
Liu Y, Hartley DP & Liu J (1998) Protection against carbon tetra-
chloride hepatotoxicity by oleanolic acid is not mediated
through metallothionein. Toxicol Lett 95, 77–85.
Lu¨ckhoff A, Pohl U, Mulsch A & Busse R (1988) Differential
role of extra- and intracellular calcium in the release of
EDRF and prostacyclin from cultured endothelial cells. Br J
Pharmacol 95, 189–196.
Lu¨scher TF & Barton M (1997) Biology of the endothelium. Clin
Cardiol 20, Suppl. 2, II-3–II-10.
Man˜ez S, Recio MC, Giner RM & Rı´os JL (1997) Effect of
selected triterpenoids on chronic dermal inflammation. Eur J
Pharmacol 334, 103–105.
Matsuda H, Li Y, Murakami T, Matsumura N, Yamahara J &
Yoshikawa M (1998) Antidiabetic principles of natural medi-
cines. III. Structure-related inhibitory activity and action
mode of oleanolic acid glycosides on hypoglycemic activity.
Chem Pharm Bull (Tokyo) 46, 1399–1403.
Mengoni F, Lichtner M, Battinelli L, Marzi M, Mastroianni CM,
Vullo V & Mazzanti G (2002) In vitro anti-HIV activity of
oleanolic acid on infected human mononuclear cells. Planta
Med 68, 111–114.
Mombouli JV & Vanhoutte PM (1999) Endothelial dysfunction:
from physiology to therapy. J Mol Cell Cardiol 31, 61–74.
Moncada S, Palmer RM & Higgs EA (1991) Nitric oxide: physi-
ology, pathophysiology, and pharmacology. Pharmacol Rev 43,
109–142.
Pe´rez-Camino MC & Cert A (1999) Quantitative determination of
hydroxy pentacyclic triterpene acids in vegetable oils. J Agric
Food Chem 47, 1558–1562.
Perona JS & Ruı´z-Gutie´rrez V (2000) Effect of two high-oleic
oils on the liver lipid composition of spontaneously hyperten-
sive rats. Life Sci 66, 521–531.
Recio MC, Giner RM, Man˜ez S & Rios JL (1995) Structural
Vasorelaxant ‘orujo’ oil components 641
requirements for the anti-inflammatory activity of natural triter-
penoids. Planta Med 61, 182–185.
Ringbom T, Segura L, Noreen Y, Perera P & Bohlin L (1998)
Ursolic acid from Plantago major, a selective inhibitor of
cyclooxygenase-2 catalyzed prostaglandin biosynthesis. J Nat
Prod 61, 1212–1215.
Somova LI, Nadar A, Rammanan P & Shode FO (2003a)
Cardiovascular, antihyperlipidemic and antioxidant effects
of oleanolic and ursolic acids in experimental hypertension.
Phytomedicine 10, 115–121.
Somova LI, Shode FO, Ramnanan P & Nadar A (2003b)
Antihypertensive, antiatherosclerotic and antioxidant activity
of triterpenoids isolated from Olea europaea, subspecies
africana leaves. J Ethnopharmacol 84, 299–305.
Tanner MA, Bu X, Steimle JA & Myers PR (1999) The direct
release of nitric oxide by gypenosides derived from the herb
Gynostemma pentaphyllum. Nitric Oxide 3, 359–365.
Vanhoutte PM (2001) Endothelium-derived free radicals: for
worse and for better. J Clin Invest 107, 23–25.
Va´zquez-Roncero A & Janer ML (1969) A´cidos triterpe´nicos del
olivo (Triterpenoid acids of the olive tree). Grasas y Aceites 20,
133–138.
Vioque E & Maza MP (1963) Sobre los a´cidos triterpe´nicos del
aceite de orujo y oliva (About orujo and olive oil triterpenic
acids). Grasas y Aceites 14, 9–11.
Vioque E & Morris LJ (1961) Minor components of olive oils.
I. Triterpenoid acids in an acetone-extracted orujo oil. J Am
Oil Chem Soc 38, 485–488.
Visioli F & Galli C (1998) The effect of minor constituents of
olive oil on cardiovascular disease: new findings. Nutr Rev
56, 142–147.
Yang D, Feletou M, Boulanger CM, Wu HF, Levens N, Zhang JN
& Vanhoutte PM (2002) Oxygen-derived free radicals mediate
endothelium-dependent contractions to acetylcholine in aortas
from spontaneously hypertensive rats. Br J Pharmacol 136,
104–110.
Yim TK, Wu WK, Pak WF & Ko KM (2001) Hepatoprotective
action of an oleanolic acid-enriched extract of Ligustrum
lucidum fruits is mediated through an enhancement on hepatic
glutathione regeneration capacity in mice. Phytother Res 15,
589–592.
Yoshikawa M & Matsuda H (2000) Antidiabetogenic activity of
oleanolic acid glycosides from medicinal foodstuffs. Biofactors
13, 231–237.
Zheng XF, Kwan CY & Daniel EE (1994) Role of
intracellular Ca2þ in EDRF release in rat aorta. J Vasc Res
31, 18–24.
Zhu YM, Shen JK, Wang HK, Cosentino LM & Lee KH (2001)
Synthesis and anti-HIV activity of oleanolic acid derivatives.
Bioorg Med Chem Lett 11, 3115–3118.
R. Rodrı´guez-Rodrı´guez et al.642
